Transient elastography in patients with cystic fibrosis
Renaud Menten1, Anissa Leonard, Philippe Clapuyt
1Radiology, Cliniques Universitaires St Luc, Avenue Hippocrate 10, Brussels 1200, Belgium. renaud.menten@rdgn.ucl.ac.be
Transient elastography (TE) offers a non-invasive method for assessing liver stiffness in cystic fibrosis (CF) patients, proving more reliable than ultrasound. This technique aids in monitoring CF-associated liver disease (CFLD) progression.
Area of Science:
- Hepatology
- Pediatric Gastroenterology
- Medical Imaging
Background:
- Cystic fibrosis (CF) frequently involves the liver, potentially leading to CF-associated liver disease (CFLD) in about 25% of patients.
- Liver biopsy, the gold standard for diagnosis, is invasive and prone to sampling errors.
- Ultrasound (US) is limited, as a normal scan does not rule out significant liver fibrosis.
Purpose of the Study:
- To prospectively compare the efficacy of transient elastography (TE) and transabdominal US in evaluating liver conditions in pediatric and adult CF patients.
- To establish TE as a reliable, non-invasive tool for assessing liver stiffness in CF patients.
Main Methods:
- 134 CF patients underwent TE immediately following routine liver US.
- Liver US appearance was graded (1-5); TE measurements (kPa) were taken ten times per patient, with the median value used.
- Control groups included 31 children without CF.
Main Results:
- No age-related correlation with liver stiffness was found in CF patients or controls.
- Lower elasticity values (US score <3) were observed in controls, pancreatic-sufficient CF patients, and pancreatic-insufficient CF patients compared to those with US score >=3 (all PI).
- Median liver stiffness was significantly higher in male CF patients (4.7 kPa) than in females (3.9 kPa).
Conclusions:
- Transient elastography (TE) presents a promising, non-invasive alternative to liver biopsy for assessing and monitoring liver disease in CF patients.
- TE's user-friendliness and reproducibility make it an attractive tool, especially given the limitations of US and the risks associated with biopsy.
More Related Videos
08:00Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study
Published on: April 11, 2018
07:04Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients
Published on: February 11, 2017
Related Concept Videos
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
